5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi

J Dermatol Sci. 2014 Feb;73(2):161-3. doi: 10.1016/j.jdermsci.2013.09.008. Epub 2013 Oct 10.

Authors

Affiliations

¹ Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.
² Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. Electronic address: [email protected].

PMID: 24169492
DOI: 10.1016/j.jdermsci.2013.09.008

No abstract available

Keywords: 5-Hydroxymethylcytosine; Biomarker; Epigenetics; Melanoma.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

5-Methylcytosine / analogs & derivatives
Adult
Aged
Aged, 80 and over
Biomarkers / metabolism
CpG Islands
Cytosine / analogs & derivatives*
Cytosine / chemistry
DNA Methylation
Epigenesis, Genetic
Female
Humans
Keratinocytes / metabolism
Male
Melanoma / diagnosis*
Melanoma / pathology
Middle Aged
Nevus, Epithelioid and Spindle Cell / metabolism
Nevus, Pigmented / diagnosis*
Nevus, Pigmented / pathology
Skin Neoplasms / diagnosis*
Skin Neoplasms / pathology

Substances

Biomarkers
5-hydroxymethylcytosine
5-Methylcytosine
Cytosine